Indeed, more than 11,000 cancer tissues have now been analyzed by genome-wide sequencing approaches via efforts such as The Cancer Genome Atlas in the decade since our initial report of cancer-guided enzyme redesign based on IDH1 mutations10. The gene discussed is IDH1; the disease is cancer.